Why is the 4DMedical share price exploding 40% today?

4DMedical signed a three-year, nationwide contract with I-MED Radiology Network.

Key points
  • 4DMedical share price rockets 40% 
  • The company announced a three-year contract with I-MED 
  • 4DMedical can now send its lung imaging technology to selected clinics among I-MED’s 250 clinic network 

The 4DMedical Ltd (ASX: 4DX) share price is surging today, up 39.6% after posting gains of as much as 95% in early morning trade.

4DMedical shares closed yesterday at 36 cents and are currently trading for 51 cents.

So what's driving ASX investor interest in the respiratory imaging technology company?

Man pointing an upward line on a bar graph symbolising a rising share price.

Image source: Getty Images

Nationwide contract inked

The 4DMedical share price is rocketing after the company reported it has signed a nationwide contract with I-MED Radiology Network. I-MED has more than 250 clinics across Australia.

The new three-year agreement formalises an existing commercial arrangement between the two companies. 4DMedical is now cleared to send its lung imaging technology to other selected clinics across I-MED's network.

Atop the agreement, the company said its agreed to establish a Lung Centre of Excellence together with I-MED. Employing its ling imaging technology, 4DMedical said the centre will "enable world-class research and development activities to advance diagnostic imaging throughout Australia".

The 4DMedical share price could also be getting a lift from the company's report that the collaboration with I-MED could streamline the adoption processes of its diagnostic imaging technology without requiring extensive pilot programs.

Commenting on the development

4DMedical CEO, Andreas Fouras said:

Expansion of our proven capability nationwide means many more people will be able to access the latest technology in respiratory imaging. Beyond putting our innovative technology in the reach of more people, this deal represents a significant opportunity to drive revenue for the company. Additionally, this agreement creates a framework for the rapid commercialisation of future 4DMedical products.

I-MED CEO Shrey Viranna added, "Activating this arrangement augments I-MED's world-class diagnostic imaging offering through access to 4DMedical's unique functional lung imaging technology."

4DMedical share price snapshot

Despite today's big lift, the 4DMedical share price remains down 59% in 2022. By comparison, the All Ordinaries Index (ASX: XAO) is down 13% year-to-date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Group of doctors celebrate by pumping fists in the air.
Healthcare Shares

Why are Mesoblast shares racing 15% higher today?

Find out what caught investor interest.

Read more »

Happy doctor using her laptop.
Healthcare Shares

Should I buy Cochlear and Mesoblast shares with $5,000?

These two companies are at different stages of their growth journeys. Here's which I'd choose for a long-term investment.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city.
Healthcare Shares

Are ResMed shares a strong buy before its results on Friday?

Here's my verdict on whether I'd buy shares before the announcement.

Read more »

A doctor looks unsure.
Healthcare Shares

Could CSL shares smash past $200 in the next 12 months?

Are CSL shares a buy, sell, or hold now?

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

3 ASX 200 healthcare shares to buy with 35% to 103% upside ahead

Are any of these ASX shares in your portfolio?

Read more »

Two health professionals working on a computer.
Healthcare Shares

How much could the CSL share price rise in the next year?

Can this healthcare giant continue with its strong rise?

Read more »

Doctor with stethoscope typing on her computer.
Healthcare Shares

Would I buy and hold CSL and Cochlear shares for 10 years?

These two businesses have different growth stories, but both stand out to me long term.

Read more »

Two doctors having a discussion about a patient diagnosis, holding digital tablet.
Healthcare Shares

The hunt for Australia's next CSL: 3 ASX healthcare shares with enormous potential

I look at three healthcare businesses that could be much larger companies in the years ahead.

Read more »